233 related articles for article (PubMed ID: 28279308)
1. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel.
Coffee B; Cox HC; Kidd J; Sizemore S; Brown K; Manley S; Mancini-DiNardo D
Cancer Genet; 2017 Feb; 211():5-8. PubMed ID: 28279308
[TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
3. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.
Coffee B; Cox HC; Bernhisel R; Manley S; Bowles K; Roa BB; Mancini-DiNardo D
Hum Mutat; 2020 Jan; 41(1):203-211. PubMed ID: 31490007
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
Slavin TP; Coffee B; Bernhisel R; Logan J; Cox HC; Marcucci G; Weitzel J; Neuhausen SL; Mancini-DiNardo D
Cancer Genet; 2019 Jun; 235-236():31-38. PubMed ID: 31056428
[TBL] [Abstract][Full Text] [Related]
5. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
Poliani L; Greco L; Barile M; Dal Buono A; Bianchi P; Basso G; Giatti V; Genuardi M; Malesci A; Laghi L;
ESMO Open; 2022 Dec; 7(6):100607. PubMed ID: 36356413
[TBL] [Abstract][Full Text] [Related]
6. Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy.
Paduano F; Colao E; Fabiani F; Rocca V; Dinatolo F; Dattola A; D'Antona L; Amato R; Trapasso F; Baudi F; Perrotti N; Iuliano R
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886069
[TBL] [Abstract][Full Text] [Related]
7. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
[TBL] [Abstract][Full Text] [Related]
8. Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing.
Mester JL; Jackson SA; Postula K; Stettner A; Solomon S; Bissonnette J; Murphy PD; Klein RT; Hruska KS
J Mol Diagn; 2020 Mar; 22(3):396-404. PubMed ID: 31881331
[TBL] [Abstract][Full Text] [Related]
9. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract][Full Text] [Related]
10. Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing.
Mancini-DiNardo D; Judkins T; Kidd J; Bernhisel R; Daniels C; Brown K; Meek K; Craft J; Holladay J; Morris B; Roa BB
BMC Med Genomics; 2019 Oct; 12(1):138. PubMed ID: 31623605
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
[TBL] [Abstract][Full Text] [Related]
12. Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories.
Rosenthal ET; Bernhisel R; Brown K; Kidd J; Manley S
Cancer Genet; 2017 Dec; 218-219():58-68. PubMed ID: 29153097
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
[TBL] [Abstract][Full Text] [Related]
14. Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing.
Sutcliffe EG; Stettner AR; Miller SA; Solomon SR; Marshall ML; Roberts ME; Susswein LR; Arvai KJ; Klein RT; Murphy PD; Hruska KS
Cancer Genet; 2020 Aug; 246-247():12-17. PubMed ID: 32805687
[TBL] [Abstract][Full Text] [Related]
15. Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
Bychkovsky BL; Agaoglu NB; Horton C; Zhou J; Yussuf A; Hemyari P; Richardson ME; Young C; LaDuca H; McGuinness DL; Scheib R; Garber JE; Rana HQ
JAMA Oncol; 2022 Nov; 8(11):1598-1606. PubMed ID: 36136322
[TBL] [Abstract][Full Text] [Related]
16. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
[TBL] [Abstract][Full Text] [Related]
17. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
medRxiv; 2023 Jan; ():. PubMed ID: 36712083
[TBL] [Abstract][Full Text] [Related]
19. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
